BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33253517)

  • 21. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma.
    Dou D; Yang S; Lin Y; Zhang J
    Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatic mining and validation of the effects of ferroptosis regulators on the prognosis and progression of pancreatic adenocarcinoma.
    Xu F; Zhang Z; Zhao Y; Zhou Y; Pei H; Bai L
    Gene; 2021 Aug; 795():145804. PubMed ID: 34175402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Postoperative prognosis prediction of pancreatic cancer with seven microRNAs.
    Lee KH; Lee JK; Choi DW; Do IG; Sohn I; Jang KT; Jung SH; Heo JS; Choi SH; Lee KT
    Pancreas; 2015 Jul; 44(5):764-8. PubMed ID: 25906450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated microRNA-mRNA analysis of pancreatic ductal adenocarcinoma.
    Liu PF; Jiang WH; Han YT; He LF; Zhang HL; Ren H
    Genet Mol Res; 2015 Aug; 14(3):10288-97. PubMed ID: 26345967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miRNA and Gene Expression in Pancreatic Ductal Adenocarcinoma.
    Tesfaye AA; Azmi AS; Philip PA
    Am J Pathol; 2019 Jan; 189(1):58-70. PubMed ID: 30558723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value.
    Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comprehensive study of construction and analysis of competitive endogenous RNA networks in lung adenocarcinoma.
    Gu C; Shi X; Huang Z; Chen J; Yang J; Shi J; Pan X
    Biochim Biophys Acta Proteins Proteom; 2020 Aug; 1868(8):140444. PubMed ID: 32423886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a 4-miRNA signature as a potential prognostic biomarker for pancreatic adenocarcinoma.
    Wang ZX; Deng TX; Ma Z
    J Cell Biochem; 2019 Oct; 120(10):16416-16426. PubMed ID: 31297864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
    Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
    J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a Multi-RNA-Type-Based Signature for Recurrence-Free Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
    Wang P; Zeng Z; Shen X; Tian X; Ye Q
    DNA Cell Biol; 2020 Apr; 39(4):615-630. PubMed ID: 32105510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of prognostic lipid droplet-associated genes in pancreatic cancer patients via bioinformatics analysis.
    Bai R; Rebelo A; Kleeff J; Sunami Y
    Lipids Health Dis; 2021 Jun; 20(1):58. PubMed ID: 34078402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Analysis of Vascular Endothelial Growth Factor (VEGF) Receptors in EUS-guided Samples Obtained from Patients with Pancreatic Adenocarcinoma.
    Costache MI; Iordache S; Costache CA; Dragos E; Dragos A; Saftoiu A
    J Gastrointestin Liver Dis; 2017 Mar; 26(1):51-57. PubMed ID: 28338114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microarray data analysis on gene and miRNA expression to identify biomarkers in non-small cell lung cancer.
    Jin X; Guan Y; Zhang Z; Wang H
    BMC Cancer; 2020 Apr; 20(1):329. PubMed ID: 32299382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated Analysis of Multi-Omics Data to Identify Prognostic Genes for Pancreatic Cancer.
    Jiang F; Huang X; Zhang F; Pan J; Wang J; Hu L; Chen J; Wang Y
    DNA Cell Biol; 2022 Mar; 41(3):305-318. PubMed ID: 35104421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Five miRNAs considered as molecular targets for predicting neuroglioma.
    Yang H; Wang Y
    Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A panel of 8 miRNAs as a novel diagnostic biomarker in pancreatic cancer.
    Deng B; Wang M; Liu Z
    Medicine (Baltimore); 2020 Sep; 99(38):e22261. PubMed ID: 32957376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of miRNA biomarkers for stomach adenocarcinoma.
    Qian H; Cui N; Zhou Q; Zhang S
    BMC Bioinformatics; 2022 May; 23(1):181. PubMed ID: 35578189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data.
    Zhang Z; Pan B; Lv S; Ji Z; Wu Q; Lang R; He Q; Zhao X
    Cell Physiol Biochem; 2018; 49(2):678-695. PubMed ID: 30165365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miRFA: an automated pipeline for microRNA functional analysis with correlation support from TCGA and TCPA expression data in pancreatic cancer.
    Borgmästars E; de Weerd HA; Lubovac-Pilav Z; Sund M
    BMC Bioinformatics; 2019 Jul; 20(1):393. PubMed ID: 31311505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.